263 related articles for article (PubMed ID: 11426467)
1. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes.
Loisel S; Le Gall C; Doucet L; Ferec C; Floch V
Hum Gene Ther; 2001 Apr; 12(6):685-96. PubMed ID: 11426467
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of proinflammatory cytokine production and liver injury induced by plasmid DNA/cationic liposome complexes with various mixing ratios in mice.
Ito Y; Kawakami S; Charoensit P; Higuchi Y; Hashida M
Eur J Pharm Biopharm; 2009 Feb; 71(2):303-9. PubMed ID: 18835442
[TBL] [Abstract][Full Text] [Related]
3. The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo.
Tan Y; Li S; Pitt BR; Huang L
Hum Gene Ther; 1999 Sep; 10(13):2153-61. PubMed ID: 10498247
[TBL] [Abstract][Full Text] [Related]
4. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes.
Li S; Huang L
Gene Ther; 1997 Sep; 4(9):891-900. PubMed ID: 9349425
[TBL] [Abstract][Full Text] [Related]
5. Lipoplexes prepared from cationic liposomes and mammalian DNA induce CpG-independent, direct cytotoxic effects in cell cultures and in mice.
Khazanov E; Simberg D; Barenholz Y
J Gene Med; 2006 Aug; 8(8):998-1007. PubMed ID: 16741997
[TBL] [Abstract][Full Text] [Related]
6. Characterization and in vivo performance of dextran-spermine polyplexes and DOTAP/cholesterol lipoplexes administered locally and systemically.
Eliyahu H; Joseph A; Schillemans JP; Azzam T; Domb AJ; Barenholz Y
Biomaterials; 2007 May; 28(14):2339-49. PubMed ID: 17298842
[TBL] [Abstract][Full Text] [Related]
7. Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid:pDNA complexes.
Yew NS; Wang KX; Przybylska M; Bagley RG; Stedman M; Marshall J; Scheule RK; Cheng SH
Hum Gene Ther; 1999 Jan; 10(2):223-34. PubMed ID: 10022547
[TBL] [Abstract][Full Text] [Related]
8. Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure.
Lindberg MF; Le Gall T; Carmoy N; Berchel M; Hyde SC; Gill DR; Jaffrès PA; Lehn P; Montier T
Biomaterials; 2015 Aug; 59():1-11. PubMed ID: 25941996
[TBL] [Abstract][Full Text] [Related]
9. Lipoplex-mediated gene delivery to the lung occurs within 60 minutes of intravenous administration.
Barron LG; Gagné L; Szoka FC
Hum Gene Ther; 1999 Jul; 10(10):1683-94. PubMed ID: 10428213
[TBL] [Abstract][Full Text] [Related]
10. Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration.
Liu F; Qi H; Huang L; Liu D
Gene Ther; 1997 Jun; 4(6):517-23. PubMed ID: 9231067
[TBL] [Abstract][Full Text] [Related]
11. Characterization of cationic lipid DNA transfection complexes differing in susceptability to serum inhibition.
Nchinda G; Uberla K; Zschörnig O
BMC Biotechnol; 2002 Jul; 2():12. PubMed ID: 12113654
[TBL] [Abstract][Full Text] [Related]
12. Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration.
Song YK; Liu F; Chu S; Liu D
Hum Gene Ther; 1997 Sep; 8(13):1585-94. PubMed ID: 9322091
[TBL] [Abstract][Full Text] [Related]
13. Characterization of cationic lipid-protamine-DNA (LPD) complexes for intravenous gene delivery.
Li S; Rizzo MA; Bhattacharya S; Huang L
Gene Ther; 1998 Jul; 5(7):930-7. PubMed ID: 9813664
[TBL] [Abstract][Full Text] [Related]
14. Calorimetric study of the interaction of binary DMTAP/DOTAP cationic liposomes with plasmid DNA.
Giatrellis S; Nikolopoulos G; Sideratou Z; Nounesis G
J Liposome Res; 2009; 19(3):220-30. PubMed ID: 19255899
[TBL] [Abstract][Full Text] [Related]
15. In vivo time-dependent gene expression of cationic lipid-based emulsion as a stable and biocompatible non-viral gene carrier.
Kwon SM; Nam HY; Nam T; Park K; Lee S; Kim K; Kwon IC; Kim J; Kang D; Park JH; Jeong SY
J Control Release; 2008 May; 128(1):89-97. PubMed ID: 18384902
[TBL] [Abstract][Full Text] [Related]
16. Enhanced gene expression in mouse lung by prolonging the retention time of intravenously injected plasmid DNA.
Song YK; Liu F; Liu D
Gene Ther; 1998 Nov; 5(11):1531-7. PubMed ID: 9930306
[TBL] [Abstract][Full Text] [Related]
17. Biodistribution and gene expression of lipid/plasmid complexes after systemic administration.
Mahato RI; Anwer K; Tagliaferri F; Meaney C; Leonard P; Wadhwa MS; Logan M; French M; Rolland A
Hum Gene Ther; 1998 Sep; 9(14):2083-99. PubMed ID: 9759935
[TBL] [Abstract][Full Text] [Related]
18. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
19. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
[TBL] [Abstract][Full Text] [Related]
20. DNA sequences in cationic lipid:pDNA-mediated systemic toxicities.
Tousignant JD; Zhao H; Yew NS; Cheng SH; Eastman SJ; Scheule RK
Hum Gene Ther; 2003 Feb; 14(3):203-14. PubMed ID: 12639301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
